journal article·2016-06-08

Strategies for Tailoring the Pore-Size Distribution of Virus Retention Filter Papers

Simon Gustafsson, Albert Mihranyan

Publisher page

Abstract

The goal of this work is to demonstrate how the pore-size distribution of the nanocellulose-based virus-retentive filter can be tailored. The filter paper was produced using cellulose nanofibers derived from Cladophora sp. green algae using the hot-press drying at varying drying temperatures. The produced filters were characterized using scanning electron microscopy, atomic force microscopy, and N2 gas sorption analysis. Further, hydraulic permeability and retention efficiency toward surrogate 20 nm model particles (fluorescent carboxylate-modified polystyrene spheres) were assessed. It was shown that by controlling the rate of water evaporation during hot-press drying the pore-size distribution can be precisely tailored in the region between 10 and 25 nm. The mechanism of pore formation and critical parameters are discussed in detail. The results are highly valuable for development of advanced separation media, especially for virus-retentive size-exclusion filtration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Cellulose Research Studies · Electrospun Nanofibers in Biomedical Applications · Surface Modification and Superhydrophobicity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Nanotechnology and Functional Materials, Department of Engineering Sciences, Uppsala University, Box 534 SE-75121, Uppsala, Sweden

Funding

Bo Rydins Stiftelse f??r Vetenskaplig Forskning · Knut och Alice Wallenbergs Stiftelse · Stiftelsen Olle Engkvist Byggm??stare

References (38)

Show source-provided references
1. 10.4161/mabs.2.5.1264510.4161/mabs.2.5.12645 ↗
2. 10.5731/pdajpst.2014.0097810.5731/pdajpst.2014.00978 ↗
3. 10.1073/pnas.74.11.514010.1073/pnas.74.11.5140 ↗
4. 10.4161/mabs.1.5.944810.4161/mabs.1.5.9448 ↗
5. Brorson K. · PDA J. Pharm. Sci. Technol. · 2008 · 62 · 334
6. Shah K. · Am. J. Epidemiol. · 1976 · 103 · 110.1093/oxfordjournals.aje.a112197 ↗
7. 10.1023/A:102296910180410.1023/A:1022969101804 ↗
8. Division of Drug Information (HFD-240), FDA-CDER. Q5a Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin;http://www.fda.gov/, 1998,09-01.
9. 10.1046/j.1537-2995.1986.26286152919.x10.1046/j.1537-2995.1986.26286152919.x ↗
10. Sanhueza, S.International Scientific Conference on Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products: 14–16 June 1995, Bethesda MD, Vaccine 1996; Vol.14, pp244–246.10.1016/0264-410X(96)90143-7 ↗
11. 10.1016/j.memsci.2007.02.04510.1016/j.memsci.2007.02.045 ↗
12. 10.1046/j.1537-2995.1985.25686071422.x10.1046/j.1537-2995.1985.25686071422.x ↗
13. 10.1016/j.jcv.2005.01.00810.1016/j.jcv.2005.01.008 ↗
14. 10.1111/j.1537-2995.2011.03420.x10.1111/j.1537-2995.2011.03420.x ↗
15. Rossio J. L. · J. Virol. · 1998 · 72 · 799210.1128/JVI.72.10.7992-8001.1998 ↗
16. 10.1007/s12257-009-0167-z10.1007/s12257-009-0167-z ↗
17. 10.1016/S0021-9673(00)01041-410.1016/S0021-9673(00)01041-4 ↗
18. 10.1007/BF0131448410.1007/BF01314484 ↗
19. 10.1016/S0165-022X(01)00207-X10.1016/S0165-022X(01)00207-X ↗
20. 10.1016/j.jeurceramsoc.2012.07.02610.1016/j.jeurceramsoc.2012.07.026 ↗
21. 10.1016/j.jwpe.2014.10.00710.1016/j.jwpe.2014.10.007 ↗
22. 10.1002/cite.20120024110.1002/cite.201200241 ↗
23. Mulder J. · 2012
24. 10.1002/polb.2185410.1002/polb.21854 ↗
25. 10.1002/adhm.20130064110.1002/adhm.201300641 ↗
26. 10.1016/j.biologicals.2015.08.00110.1016/j.biologicals.2015.08.001 ↗
27. 10.1023/A:100921262877810.1023/A:1009212628778 ↗
28. 10.1007/s10570-011-9630-z10.1007/s10570-011-9630-z ↗
29. 10.1007/s10570-011-9629-510.1007/s10570-011-9629-5 ↗
30. 10.1002/anie.20100127310.1002/anie.201001273 ↗
31. 10.1007/s10570-010-9405-y10.1007/s10570-010-9405-y ↗
32. 10.1002/app.3295910.1002/app.32959 ↗
33. 10.1021/ja01269a02310.1021/ja01269a023 ↗
34. 10.1021/ja01145a12610.1021/ja01145a126 ↗
35. 10.1002/cite.20100006410.1002/cite.201000064 ↗
36. 10.1351/pac19855704060310.1351/pac198557040603 ↗
37. 10.1021/ab500161x10.1021/ab500161x ↗
38. 10.1021/acs.biomac.6b0005310.1021/acs.biomac.6b00053 ↗